InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,468.09
(
-0.09%
)
US TECH 100
19,205.60
(
-0.28%
)
Dow Jones
39,168.56
(
0.09%
)
Brent Oil
84.39
(
-0.73%
)
Bitcoin
64,038.71
(
-1.21%
)
Post# of 48316
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TheEconomist

Send PM Follow Ignore
Followers 13
Posts 498
Boards Moderated 0
Alias Born 02/20/2013

TheEconomist

Re: zoriden post# 5069

Thursday, 10/03/2013 10:06:20 AM

Thursday, October 03, 2013 10:06:20 AM

Post# of 48316
I agree with you Zoriden. I owned INO at approximately the same price. INO and ONCS share some similarities; however ONCS is further along with their clinical trials than INO. Now is the best time to buy. I am still buying 1000 or more shares here and there
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ONCSQ News
More ONCSQ News
InvestorsHub NewsWire

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

Start posting your company's news
Only $200 per official company press release!